Music |
Video |
Movies |
Chart |
Show |
Discussing Rheumatology: Baricitinib Safety and Treatment Interruptions (The Immune-Mediated Inflammatory Disease Forum) View | |
Discussing Rheumatology: Baricitinib and Itacitinib (The Immune-Mediated Inflammatory Disease Forum) View | |
Discussing Rheumatology: JAK Inhibitor Monotherapy in RA (The Immune-Mediated Inflammatory Disease Forum) View | |
Discussing Rheumatology: Tofacitinib Improves PROs (The Immune-Mediated Inflammatory Disease Forum) View | |
Discussing Rheumatology: JAKi and Bone Biology (The Immune-Mediated Inflammatory Disease Forum) View | |
Discussing Rheumatology: Vasculitis u0026 Zoster (The Immune-Mediated Inflammatory Disease Forum) View | |
RheumNow Podcast – Tofacitinib Safety Concerns (2.5.2021) (RheumNow) View | |
Repurposing rheumatology drugs for COVID-19: JAK inhibitors (Medicine Matters rheumatology) View | |
ACR 2020 | Peter Taylor comments on the SEAM-RA trial (Medicine Matters rheumatology) View | |
JAK inhibitors in rheumatic diseases (RheumNow) View |